| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/23/2004 | CN1154732C Synthetic HPV6/11 hybrid Li DNA encoding human papliomavirus type 11 L1 protein |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154660C Hybrid molecules between heat-labile enterotoxin and cholera toxic B subunits |
| 06/23/2004 | CN1154659C Novel anti-AIDS immunotoxins |
| 06/23/2004 | CN1154509C Multivalent vaccine compsn. with mixed carrier |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/22/2004 | US6753423 For preferentially modulated gene expression in liver and associated tissues |
| 06/22/2004 | US6753417 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 06/22/2004 | US6753183 Immunologically active proteins from Borrelia burgdorferi |
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753172 For the treatment of bacterial infection, detecting diseases related to the presence of fabi nucleic acid sequences |
| 06/22/2004 | US6753166 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases |
| 06/22/2004 | US6753149 For producing vaccines for the prevention or attenuation of infection by staphylococcus |
| 06/22/2004 | US6753015 Microparticle compositions and methods for the manufacture thereof |
| 06/22/2004 | US6752996 Adjuvant for poorly immunogenic tumor vaccines and subunit vaccines, such as those for preventing and/or treating flu, tuberculosis, respiratory syncytial virus, anthrax and hiv. |
| 06/22/2004 | US6752995 Nucleic acid and polypeptide sequences useful as adjuvants |
| 06/22/2004 | US6752994 Microorganismal cell model for use as tool in treatment of tuberculosis, skin disorders and infections |
| 06/22/2004 | US6752993 Abundant extracellular product vaccines and methods for their production and use |
| 06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/22/2004 | CA2210620C Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 06/22/2004 | CA2176926C .alpha.v.beta.3 integrin as a predictor of endometriosis |
| 06/22/2004 | CA2164672C Process for purifying hepatitis b viral surface antigen comprising pres2 peptide |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/22/2004 | CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
| 06/22/2004 | CA2088471C Method for determining rheumatoid factors and agents for carrying out the method |
| 06/19/2004 | CA2452946A1 Detection and diagnosis of transmissible spongiform encephalopathies |
| 06/17/2004 | WO2004050900A2 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 06/17/2004 | WO2004050895A2 Methods and compositions for inducing apoptosis in cancer cells |
| 06/17/2004 | WO2004050883A2 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |
| 06/17/2004 | WO2004050876A1 A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050856A2 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
| 06/17/2004 | WO2004050855A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 06/17/2004 | WO2004050846A2 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 06/17/2004 | WO2004050829A2 Recombinant double-stranded rna phage, and use of the same |
| 06/17/2004 | WO2004050711A2 Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
| 06/17/2004 | WO2004050692A2 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production |
| 06/17/2004 | WO2004050691A2 A method for the production of hiv-1 gag virus-like particles |
| 06/17/2004 | WO2004050119A1 Vaccine against enteropathogenic and enterohaemorragic escherichia coli |
| 06/17/2004 | WO2004050111A2 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 06/17/2004 | WO2004050065A1 Intraocular delivery compositions and methods |
| 06/17/2004 | WO2004049907A2 Compositions and methods for treating transplants |
| 06/17/2004 | WO2004033677A3 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 06/17/2004 | WO2004031767A3 Prevention of primary sjögren’s syndrome by ica69 deficiency |
| 06/17/2004 | WO2004030685A3 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 06/17/2004 | WO2004026024A3 Vaccine compositions and adjuvant |
| 06/17/2004 | WO2003075831A3 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 06/17/2004 | WO2003073351A3 Screening process |
| 06/17/2004 | WO2003063770A9 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/17/2004 | WO2003059387A3 Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis |
| 06/17/2004 | WO2003059259A3 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 06/17/2004 | WO2003053334A3 Compositions and methods for the diagnosis and treatment of tumor |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | WO2003015813A3 Anti-tumor vaccines |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | US20040116684 Progenitor viral nucleotide sequences for generating vaccines to prevent viral infection during xenogenic tissue and/or organ transplantation; tissue engineering |
| 06/17/2004 | US20040116671 Novel polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040116667 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy |
| 06/17/2004 | US20040116665 Vaccine composition |
| 06/17/2004 | US20040116664 Chimeric protein comprising multiprotein complex for use in development of influenza vaccine |
| 06/17/2004 | US20040116661 Virulence peptides from attenuated microorganism for identifying microbiocides and developing vaccines which prevent infection; veterinary medicine |
| 06/17/2004 | US20040116660 Identifying lymphadenopathy associated viral variants and using sequence homologies in envelope proteins to generate concensus sequence for use in developing vaccine aganist infection; immunotherapy; viricides |
| 06/17/2004 | US20040116379 capable of enhancing efficacy of vaccines; capable of enhancing the action of an agent in preventing tissue rejection |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040116367 Production of "biological carriers" for induction of immune responses and inhibition of viral replication |
| 06/17/2004 | US20040116363 Useful in vaccine effective against Mannheimia haemolytica in animals |
| 06/17/2004 | US20040116337 Soluble cyclic analogues of beta amyloid peptide |
| 06/17/2004 | US20040116333 Administering to the individual a multimeric compound that binds to at least two P-Selectin Glycoprotein Ligand 1 (PSGL-1) proteins on the surface of a T cell to induces a signal transduction pathway that results in the death of the T cell |
| 06/17/2004 | US20040115809 Propagating cytotoxic lymphocytes with specific toxicity in the presence of antigen presenting cells for use in treatment of tumors and viral infections; immunotherapy |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115772 Methods of inhibiting Helicobacter pylori |
| 06/17/2004 | US20040115767 Immunogenic cell surface proteins of helicobacter pylori |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115690 Method of detecting inflammatory lung disorders |
| 06/17/2004 | US20040115656 Androgen receptor down-regulatory-associated proteins(ARDAPs) for use in reduction of transactivation activity of androgen receptors and treatment of tumors; gene expression inhibition and anticarcinogenic agents |
| 06/17/2004 | US20040115622 Mixture of peptides originating from a Nef protein and applications thereof |
| 06/17/2004 | US20040115621 Ancestral viruses and vaccines |
| 06/17/2004 | US20040115620 Adenoviral replicons |
| 06/17/2004 | US20040115619 Immunoglobulin which binds hepatitis c viral envelope proteins and prevents and treats viral diseases; immunotherapy; viricides |
| 06/17/2004 | US20040115615 Comprises amino acid sequences capable of inducing lymphadenopathy immune response without antagonizing cytotoxic lymphocytes; viricides and prevention of viral diseases |
| 06/17/2004 | US20040115283 Administering parenterally a therapeutically effective amount of one or more arsenic compounds |
| 06/17/2004 | US20040115224 Preparation and administration of hybrid cell vaccines for the prevention of cancer |
| 06/17/2004 | US20040115223 Prevention and treatment of allergies by helminthic regulation of IgE |
| 06/17/2004 | US20040115221 Intracellular delivery vehicles |
| 06/17/2004 | US20040115220 Vaccine |
| 06/17/2004 | US20040115219 Pharmaceutical composition for prophylaxis and therapy of papillomavirus-derived diseases comprising papillomavirus antigen protein and CpG-oligodeoxynucleotide |
| 06/17/2004 | US20040115218 Ubiquitin fusion-based vaccine system |
| 06/17/2004 | US20040115217 Bystander suppression of autoimmune diseases |
| 06/17/2004 | US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 06/17/2004 | US20040115215 Recombinant botulinum toxins with a soluble C-terminal portion, an N-terminal portion and a light chain |
| 06/17/2004 | US20040115213 Use of IL-2 receptor antibodies |
| 06/17/2004 | US20040115212 Attenuated microorganism strains and their uses |
| 06/17/2004 | US20040115211 fusions between ESAT-6 and MPT59 are superior immunogens |
| 06/17/2004 | US20040115210 Imunogenic complex comprising ribosomes |
| 06/17/2004 | US20040115206 by contacting with an anti-L1CAM antibody or L1CAM-binding fragment thereof to inhibit cell growth or induce cell death |
| 06/17/2004 | US20040115205 Use of antibodies against the MUC18 antigen |
| 06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |
| 06/17/2004 | US20040115199 Method for down-regulating osteoprotegerin ligand activity |